Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion evidence source_evidence_literature NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion SIO_000772 14961035 NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion wasDerivedFrom befree-20140225 NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_assertion wasGeneratedBy ECO_0000203 NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP497417.RA0fjND927B1IwHRwAjkQyS2R11NAGSfE6KIt18YezZLs130_provenance.